ASX All Ords Stocks Getting Propelled by News

From the ASX listed companies, two healthcare stocks were racing higher today. Backed by new distribution arrangements, the two emerge as growing companies to invest in.

Clarity Pharmaceuticals Limited (ASX: CU6)

Clarity Pharmaceuticals has entered into a new supply agreement with The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (UQ AIBN) to secure a consistent source of copper-64 (Cu-64) for its expanding clinical and pre-clinical programs. The agreement will support the ongoing Phase III CLARIFY and AMPLIFY trials for Clarity’s diagnostic agent 64Cu-SAR-bisPSMA, which is being developed for prostate cancer imaging. Additionally, the supply will contribute to the Co-PSMA investigator-initiated trial at St Vincent’s Hospital in Sydney and the SECuRE theranostic trial in Australia. Beyond its clinical trials, Clarity will also use the Cu-64 supply for its pre-clinical programs, including the development of SAR-bisFAP and SAR-trastuzumab theranostic products.

Read More - https://bit.ly/ASX-Stocks